VuCOMP, Inc. will exhibit its new, automated breast density measurement
technology, M-Vu Breast Density, at the American College of Radiology
(ACR) 36th National Conference on Breast Cancer (NCBC) in booth 501 from
May 8-10 at the Arizona Biltmore in Phoenix.
Clinical studies have shown that dense breasts can make breast cancer
detection in a mammogram more difficult by potentially masking malignant
masses. Because of this, radiologists classify breast density into four
categories established by the American College of Radiology's Breast
Imaging Reporting and Data System (BI-RADS) standard.
M-Vu Breast Density automatically and rapidly evaluates mammograms in
much the same manner as experienced radiologists do: by analyzing the
structure and texture of the tissue, rather than simply estimating total
fibroglandular volume. The algorithms quantify areas with a dense
appearance which could hide cancer and convert this to categories
corresponding to te recently updated BI-RADS standard. This exclusive
approach using appearance-based analysis provides useful adjunctive
"We designed M-Vu Breast Density to analyze the appearance of
fibroglandular tissue rather than using a volumetric approach. This
focuses our product more directly on identifying areas that could mask
cancers. We believe this better aligns with the new ACR BI-RADS
categories," said VuCOMP COO Barry Burgdorf. "We're very pleased to
welcome to our booth both users and those interested in M-Vu Breast
Density. They will have the opportunity to learn more about how it is
providing patients with significant clinical benefits."
VuCOMP recently released its second version M-Vu Breast Density system,
Version 2.0, an enhancement that was made immediately available to
existing customers as well as to new customers.
In addition to M-Vu Breast Density, the company will be demonstrating
M-Vu Computer-Aided Detection (CAD) for mammography. M-Vu CAD analyzes
mammograms to mark areas consistent with breast cancer using
sophisticated mathematical algorithms. VuCOMP is the only company in
world to offer both categories of breast cancer detection technology.
About VuCOMP, Inc.
VuCOMP, Inc. leads the way in setting a new standard for CAD and breast
density measurement. The company is dedicated exclusively to developing
advanced cancer detecting technologies. VuCOMP's engineering team has
worked together since 1986, pioneering some of the world's most advanced
computer vision systems. For more information, please visit www.vucomp.com.
[ Back To NFVZone's Homepage ]